节点文献

脊髓性肌萎缩症患者利司扑兰治疗药物监测方法研究

Study on Therapeutic Drug Monitoring Method of Risdiplam in Patients with Spinal Muscular Atrophy

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 吴献黄晓会林志燕刘艳蒋文高刘昕竹张健

【Author】 WU Xian;HUANG Xiaohui;LIN Zhiyan;LIU Yan;JIANG Wengao;LIU Xinzhu;ZHANG Jian;College of Pharmacy,Chongqing Medical University;Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine;

【通讯作者】 张健;

【机构】 重庆医科大学药学院上海交通大学医学院附属新华医院

【摘要】 目的 建立脊髓性肌萎缩症患者利司扑兰治疗药物监测的方法。方法 采用超高效液相色谱串联质谱法,色谱柱为Phenomenex Kinetex XB C18柱(50 mm×3 mm,2.6μm),流动相为0.07%甲酸水溶液(pH 4.5)-0.07%甲酸乙腈溶液(pH 5.5),梯度洗脱,流速为0.3 mL/min,柱温为40℃,进样量为2μL;采用电喷雾离子源(正离子模式),多反应监测模式,利司扑兰的离子对m/z分别为402.2→319.2、402.2→374.4,RG7800的离子对m/z为417.3→360.2。结果 利司扑兰质量浓度在1.95~125.00 ng/mL范围内与其峰面积与内标峰面积比值线性关系良好(R2=0.999 1,n=8),定量限为1.95 ng/mL;基质效应试验结果的变异系数均小于12%;精密度、稳定性试验结果的RSD均小于20%,准确度分别为87%~108%、87%~113%。6例患者利司扑兰血药浓度为13.03~91.14 ng/mL。结论 该方法操作简便、高效快速,可用于脊髓性肌萎缩症患者利司扑兰的治疗药物监测。

【Abstract】 Objective To establish a therapeutic drug monitoring (TDM) method of risdiplam in patients with spinal muscular atrophy.MethodsUltra-high-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) was adopted,the chromatographic column was the Phenomenex Kinetex XB C18 column (50 mm×3 mm,2.6μm),the mobile phase was0.07%formic acid aqueous solution (pH 4.5)-0.07%formic acid acetonitrile solution (pH 5.5) with gradient elution,the flow rate was 0.3 mL/min,the column temperature was 40℃,and the injection volume was 2μL.The electro-spray ionization was adopted with positive ion mode and multiple reaction monitoring mode.The mass-to-charge ratios (m/z) were 402.2→319.2 (risdiplam),402.2→374.4 (risdiplam) and 417.3→360.2 (RG7800).ResultsThe linear range of risdiplam was1.95-125.00 ng/mL (R2=0.999 1,n=8).The limit of quantitation was 1.95 ng/mL.The coefficient of variation of the matrix effect test was lower than 12%.The RSDs of precision and stability tests were lower than 20%,with accuracy ranging from 87% to 108% and 87% to 113%,respectively.The plasma concentration of risdiplam in six patients was in the range of 13.03 to 91.14 ng/mL.ConclusionThis method is easy,efficient and fast,which can be used for TDM of risdiplam in patients with spinal muscular atrophy.

【基金】 中国药学会医院药学专业委员会人才专项资助项目[CPA-Z05-ZC-2022-003];教育部·上海市生物医药临床研究与转化协同创新中心重点科研项目[CCTS-2022205]
  • 【文献出处】 中国药业 ,China Pharmaceuticals , 编辑部邮箱 ,2024年12期
  • 【分类号】R969.1
  • 【下载频次】15
节点文献中: 

本文链接的文献网络图示:

本文的引文网络